Effect of Variant Alleles SLCO1B1 and ABCG2 on Pharmacokinetics of Rosuvastatin in Healthy Volunteers.

Trial Profile

Effect of Variant Alleles SLCO1B1 and ABCG2 on Pharmacokinetics of Rosuvastatin in Healthy Volunteers.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 21 May 2012 Planned End Date changed from 30 Dec 2010 to 31 Mar 2011 as reported by Chinese Clinical Trial Register record.
    • 19 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top